from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1377c/-

LFCtreatmentdescriptionclass of inhibitor

-1.189

Amikacinug/mL Amikacintranslation

-0.880

Cap5-10ug/mL Capreomycintranslation

-0.946

Rox10-50 ug/mL Roxithromycintranslation

-0.958

SM2-5 ug/mL Streptomycintranslation

-0.920

Tet5-10 ug/mL Tetracyclinetranslation

-0.524

Rif0.2-5ug/mL Rifampicintranscription

-0.726

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.007

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.940

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.100

CPZ10-50 ug/mL Chlorpromazinerespiration

0.377

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.854

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.618

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.450

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.304

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.668

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.238

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.481

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.072

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.297

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.594

KCN5-20 ug/mL Potassium cyaniderespiration

-0.518

NaN30.2-2 mM Sodium aziderespiration

-0.513

Nigericin50 uM Nigericinrespiration

0.496

TRC10-150 ug/mL Triclosanrespiration

1.009

TRZ10-25 ug/mL Thioridazinerespiration

0.214

Valinomycin0.5-10 uM Valinomycinrespiration

-2.372

ZnSO42 mM ZnSO4respiration

-0.197

menadione6-10 ug/mL Menadionerespiration

0.193

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.257

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.338

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.652

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.962

NRP_1Non-replicating persistence stage 1dosRassociated

-0.438

Amp0.2mg/mL AmpicillincellWall

-0.121

Cephalexin20-100 ug/mL CephalexincellWall

-0.557

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.402

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.647

EMB10-20 ug/mL EthambutolcellWall

-1.220

Eta12-40 ug/mL EthionamidecellWall

-1.361

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.642

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.801

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.136

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.113

BZA0.12 mg/mL BenzamidearomaticAmides

0.080

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.274

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.087

H2O24 mM hydrogen peroxideDNAdamaging

1.970

Levo10 ug/mL LevofloxacinDNAdamaging

0.008

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.463

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.047

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.176

UVUV-irradiationDNAdamaging

0.380

ARP41-4 ug/mL Antitubercular compound ARP4?

1.057

Antimycin12.5-50 ug/mL Antimycin A?

-0.516

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.963

PA_110-50 ug/mL Antitubercular compound PA-1?

0.737

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.016

PA8240.2-2 ug/mL PA-824?

0.044

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.325

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.004

Verapamil50 uM Verapamil?

-0.085

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.689

methoxatin10-20 ug/mL Methoxatin?